EX-99 6 f4130448e.txt EXHIBIT 99.5 JOINT FILER INFORMATION FOR ORACLE INVESTMENT MANAGEMENT Exhibit 99.5 FORM 4 JOINT FILER INFORMATION (Attachment to Form 4 in accordance with instruction 4(b)(v)) Check this box if no longer subject to Section 16: [ X ] Name and Address: Oracle Investment Management, Inc. 200 Greenwich Avenue, 3rd Floor Greenwich, CT 06830 Issuer and Ticker Symbol: Access Pharmaceuticals, Inc. ("ACCP") Date of Earliest Transaction: 2/12/08 Relationship to Issuer: 10% Owner Designated Filer: Larry N. Feinberg TABLE I INFORMATION Title of Security: Common Stock Transaction Date: 2/12/2008 Transaction Code: S Securities Disposed: 29,736 Acquired or Disposed: D Price: $3.15 Ownership Form: I Amount Beneficially Owned After Transaction (14) Nature of Indirect Beneficial Ownership (13) TABLE II INFORMATION Title of Derivative Security: Preferred Stock Conversion or Exercise Price of Derivative Security (6) Transaction Date: 11/10/2007 Transaction Code: S (7) Securities Acquired: 86 Date Exercisable and Expiration Date: (6) Title of Underlying Securities: Common Stock Amount of Underlying Securities: 240,000 Price of Derivative Securities: $6,885.00 Number Beneficially Owned 86 Ownership Form: I Nature of Indirect Beneficial Ownership (13) Title of Derivative Security: Warrants Conversion or Exercise Price of Derivative Security (9) Transaction Date: 11/10/2007 Transaction Code: S Securities Acquired: 143,773 Date Exercisable and Expiration Date: (9) Title of Underlying Securities: Common Stock Amount of Underlying Securities: 143,773 Price of Derivative Securities: (7) Number Beneficially Owned 143,773 Ownership Form: I Nature of Indirect Beneficial Ownership (13) Explanation of Responses: (6), (7), (9), (13) and (14): See Exhibit 99.1. Signature: ORACLE INVESTMENT MANAGEMENT, INC. By: /s/ Larry N. Feinberg --------------------------------- Name: Larry N. Feinberg Title: President Date: June 10, 2008